Data Sheet 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.pdf
Introduction<p>Fibrates are effective triglyceride-lowering drugs, but they may affect bile acid metabolism, raising concerns about biliary adverse drug events (ADEs).</p>Objective<p>In this study, we used spontaneous reporting system databases to evaluate the association between f...
Uloženo v:
| Hlavní autor: | Satoko Watanabe (59124) (author) |
|---|---|
| Další autoři: | Kyosuke Nagura (22675574) (author), Naoto Okada (7836800) (author), Taro Watanabe (15278960) (author), Hidenori Sagara (22675577) (author) |
| Vydáno: |
2025
|
| Témata: | |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
Autor: Satoko Watanabe (59124)
Vydáno: (2025) -
Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
Autor: Satoko Watanabe (59124)
Vydáno: (2025) -
Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
Autor: Satoko Watanabe (59124)
Vydáno: (2025) -
Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx
Autor: Satoko Watanabe (59124)
Vydáno: (2025) -
Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx
Autor: Han Qu (4391905)
Vydáno: (2025)